Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender
- People who need at least 2 blood transfusions within every 28-day period (known as being "transfusion dependent")
- People who receive their cancer care at SKCCC (Sidney Kimmel Comprehensive Cancer Center)
- People who have a history of receiving blood transfusions but have never had a reaction to a transfusion
- People who live within 30 miles of the Center City SKCCC location
- People who are willing to allow trial staff or team members into their home
- People who are willing to follow all study procedures and remain available for the full duration of the study
- People who have signed and dated a consent form agreeing to take part
Who may not be able to join:
- People who have ever had a reaction to a blood transfusion
- People with heart failure classified as AHA Stage C or NYHA Class II–IV (confirm with trial site if unsure which category applies)
- People who do not speak English or Spanish
- People who are currently without stable housing
- People who are currently incarcerated
- People who have poor vein access, making it difficult to draw blood or give transfusions
- People whose cancer is a solid tumour (as opposed to a blood cancer)
- People who are currently pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adam Binder, MD, Adam.Binder@jefferson.edu
Phone: 215-955-8874
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of a home blood transfusion program utilizing the RE-AIM framework; Acceptability of a home blood transfusion program utilizing the RE-AIM framework
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.